The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns and outcomes in patients diagnosed with metastatic pancreatic ductal adenocarcinoma (PDAC) and by methylthioadenosine phosphorylase (MTAP) status.
 
Reginald Villacorta
Employment - Bristol Myers Squibb Foundation
Stock and Other Ownership Interests - Bristol Myers Squibb Foundation
 
Ijeoma Oyetunde
Employment - Bristol Myers Squibb Foundation
Stock and Other Ownership Interests - Bristol Myers Squibb Foundation
 
Lisa Rosenblatt
Employment - Bristol Myers Squibb
Stock and Other Ownership Interests - Amgen Astellas BioPharma (I); Bristol Myers Squibb; Merck (I)
Travel, Accommodations, Expenses - Bristol Myers Squibb
 
Ching An Wang
Employment - Bristol Myers Squibb Foundation
Stock and Other Ownership Interests - Bristol Myers Squibb Foundation
 
Min You
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol Myers Squibb Foundation
 
E. Gabriela Chiorean
Consulting or Advisory Role - AADi; Astellas Pharma; BPGbio; Bristol-Myers Squibb/Celgene; IgM Biosciences; Ipsen; Merus; Pfizer; Purple Biotech; Regeneron; Takeda
Research Funding - Affini-T Therapeutics (Inst); BioAtla; Boehringer Ingelheim (Inst); Erasca, Inc (Inst); FibroGen (Inst); Genentech (Inst); Gilead/Forty Seven (Inst); Lonza (Inst); Merck (Inst); Mirati Therapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Merus